Abl Bio, Inc.
Clinical trials sponsored by Abl Bio, Inc., explained in plain language.
-
New antibody combo aims to shrink tough tumors
Disease control Recruiting nowThis study tests a new drug called ABL103 combined with pembrolizumab (with or without a chemotherapy called taxane) in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the combination is safe and can shrink or control t…
Phase: PHASE1, PHASE2 • Sponsor: ABL Bio, Inc. • Aim: Disease control
Last updated Jun 17, 2026 12:10 UTC
-
New antibody drug takes on Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new drug called ABL103 in people with advanced solid tumors that have not responded to standard treatments. The drug is designed to help the immune system attack cancer cells. The main goals are to check safety, find the right dose, and see if it sh…
Phase: PHASE1 • Sponsor: ABL Bio, Inc. • Aim: Disease control
Last updated Jun 08, 2026 13:04 UTC